103 related articles for article (PubMed ID: 7121446)
1. The remarkable substrate activity for phenylethanolamine N-methyltransferase of some conformationally defined phenylethylamines lacking a side-chain hydroxyl group. Conformationally defined adrenergic agents. 6.
Rafferty MF; Grunewald GL
Mol Pharmacol; 1982 Jul; 22(1):127-32. PubMed ID: 7121446
[No Abstract] [Full Text] [Related]
2. Importance of the aromatic ring in adrenergic amines. Nonaromatic analoques of phenylethanolamine as substrates for phenylethanolamine N-methyltransferase.
Grunewald GL; Grindel JM; Vincek WC; Borchardt RT
Mol Pharmacol; 1975 Sep; 11(5):694-9. PubMed ID: 1237082
[No Abstract] [Full Text] [Related]
3. Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
Grunewald GL; Ye Q; Sall DJ; Criscione KR; Wise B
Mol Pharmacol; 1989 Jan; 35(1):93-7. PubMed ID: 2913486
[TBL] [Abstract][Full Text] [Related]
4. The effect of beta-adrenergic blocking agents on the rat adrenal phenylethanolamine-N-methyltransferase activity.
Janiec W; Lukas W; Glogowski A
Pol J Pharmacol Pharm; 1973; 25(3):237-41. PubMed ID: 4150017
[No Abstract] [Full Text] [Related]
5. Conformational requirements of substrates for activity with phenylethanolamine N-methyltransferase.
Grunewald GL; Ye Q; Kieffer L; Monn JA
J Med Chem; 1988 Jan; 31(1):169-71. PubMed ID: 3336016
[TBL] [Abstract][Full Text] [Related]
6. Conformational preferences of amphetamine analogues for inhibition of phenylethanolamine N-methyltransferase. Conformationally defined adrenergic agents. 5.
Grunewald GL; Borchardt RT; Rafferty MF; Krass P
Mol Pharmacol; 1981 Sep; 20(2):377-81. PubMed ID: 7300818
[No Abstract] [Full Text] [Related]
7. Position of a chloro substituent on phenylethanolamine as a determinant of methylation by rabbit adrenal norepinephrine N-methyltransferase.
Fuller RW; Hemrick SK; Molloy BB
Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):577-80. PubMed ID: 928956
[No Abstract] [Full Text] [Related]
8. Conformational preferences of dopamine analogues for inhibition of norepinephrine N-methyltransferase. Conformationally defined adrenergic agents.
Grunewald GL; Pleiss MA; Rafferty MF
Life Sci; 1982 Sep; 31(10):993-1000. PubMed ID: 7132559
[TBL] [Abstract][Full Text] [Related]
9. Stereochemical aspects of phenylethanolamine analogues as substrates of phenylethanolamine N-methyltransferase.
Grunewald GL; Ye QH
J Med Chem; 1988 Oct; 31(10):1984-6. PubMed ID: 3172133
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of N-and O-methyltransferases.
Axelrod J; Vesell ES
Mol Pharmacol; 1970 Jan; 6(1):78-84. PubMed ID: 5527525
[No Abstract] [Full Text] [Related]
11. Comparison of o-octopamine and related phenylethanolamines as substrates for norepinephrine N-methyltransferase.
Fuller RW; Hemrick-Luecke SK; Midgley JM
Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):207-13. PubMed ID: 6795705
[TBL] [Abstract][Full Text] [Related]
12. Importance of the aromatic ring in adrenergic amines. 8. 2-(Aminomethyl)-trans-2-decalols as inhibitors of norepinephrine N-methyltransferase.
Rafferty MF; Krass P; Borchardt RT; Grunewald GL
J Med Chem; 1982 Oct; 25(10):1250-2. PubMed ID: 7143367
[TBL] [Abstract][Full Text] [Related]
13. The binding order of substrates to phenylethanolamine N-methyltransferase.
Pendleton RG; Snow IB
Mol Pharmacol; 1973 Nov; 9(6):718-25. PubMed ID: 4762633
[No Abstract] [Full Text] [Related]
14. Regulation of synthesis and degradation of rat adrenal phenylethanolamine N-methyltransferase. IV. Synergistic stabilization of the enzyme against thermal and tryptic degradation by S-adenosylmethionine and biogenic amine substrates.
Masover SJ; Berenbeim DM; Ciaranello RD
Mol Pharmacol; 1979 Sep; 16(2):491-503. PubMed ID: 514255
[No Abstract] [Full Text] [Related]
15. Regulation of phenylethanolamine N-methyltransferase synthesis and degradation. I. Regulation by rat adrenal glucocorticoids.
Ciaranello RD
Mol Pharmacol; 1978 May; 14(3):478-89. PubMed ID: 351371
[No Abstract] [Full Text] [Related]
16. Regulation of synthesis and degradation of rat adrenal phenylethanolamine N-methyltransferase. III. Stabilization of PNMT against thermal and tryptic degradation by S-adenosylmethionine.
Berenbeim DM; Wong DL; Masover SJ; Ciaranello RD
Mol Pharmacol; 1979 Sep; 16(2):482-90. PubMed ID: 514254
[No Abstract] [Full Text] [Related]
17. Importance of the aromatic ring in adrenergic amines. 5. Nonaromatic analogues of phenylethanolamine as inhibitors of phenylethanolamine N-methyltransferase: role of hydrophobic and steric interactions.
Vincek WC; Aldrich CS; Borchardt RT; Grunewald GL
J Med Chem; 1981 Jan; 24(1):7-12. PubMed ID: 7205880
[No Abstract] [Full Text] [Related]
18. Substrate and inhibitor kinetics of bovine phenylethanolamine-N-methyltransferase.
Hoffman AR; Ciaranello RD; Axelrod J
Biochem Pharmacol; 1975 Feb; 24(4):544-6. PubMed ID: 1167462
[No Abstract] [Full Text] [Related]
19. Regulation of phenylethanolamine N-methyltransferase synthesis and degradation. II. Control of the thermal stability of the enzyme by an endogenous stabilizing factor.
Ciaranello RD; Wong DL; Berenbeim DM
Mol Pharmacol; 1978 May; 14(3):490-501. PubMed ID: 207972
[No Abstract] [Full Text] [Related]
20. Conformationally restricted and conformationally defined tyramine analogues as inhibitors of phenylethanolamine N-methyltransferase.
Ye QH; Grunewald GL
J Med Chem; 1989 Feb; 32(2):478-86. PubMed ID: 2913308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
